explore -WSS

explore

author：hotspot 2025-10-01 16:41:05 - browse：669

A syringe is prepared at a clinic in Norristown, Pa., Dec. 7, 2021. The Environmental Protection Agency finalized a rule Thursday, March 14, 2024, imposing stricter limits on a chemical used to sterilize medical equipment after finding a higher-than-expected cancer risk at facilities that use ethylene oxide to clean billions of devices including catheters and syringes. ( — The agency first proposed limits on the gas in April 2023, with the goal of reducing emissions by 80%. Now, the agency is predicting an emissions reduction of 90%. Matt Rourke/Ap

On Thursday, the Environmental Protection Agency finalized limits on a carcinogenic gas called ethylene oxide that is used to sterilize most medical devices. Sterilizing facilities had polluted the air unchecked for decades, leading to disproportionately high cancer risks in surrounding communities.

The agency first proposed limits on the gas in April 2023, with the goal of reducing emissions by 80%. Now, the agency is predicting an emissions reduction of 90%. The rule will require commercial sterilization facilities to monitor and submit proof of their reduced emissions. It aligns with the Biden administration’s greater mission to end cancer and commitment to environmental justice, the EPA said.

Ethylene oxide is the most frequently used sterilizing chemical for devices that can’t be exposed to steam. It’s used to sanitize 20 billion devices in the U.S. per year, such as pacemakers, catheters, and ventilators. But long-term exposure to the gas can cause breast cancer, non-Hodgkin’s lymphoma, lymphocytic leukemia, and myeloma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Cholera vaccine supply gets boost as demand surges globally

WSS

More tobacco lobbyists active in statehouses

UnitedHealth financials solid despite Change Healthcare cyberattack

Element Biosciences CEO lays out genome sequencing strategy

Melinda French Gates resigns from Gates Foundation

Q&A: Jennifer Adair on making gene therapy available globally

Medtronic CEO on promising devices for diabetes, hypertension

leisure time

explore

hotspot

Alkermes shareholders re

Meta's Zuckerberg and Chan on track to put $50 billion into science

Malaria cases in Florida and Texas: Here’s what you need to know

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Apple is now the first public company to be valued at $3 trillion

Meta's Zuckerberg and Chan on track to put $50 billion into science

Supreme Court strikes down use of affirmative action

Diversifying clinical trials isn't enough to close racial gaps: study

Tori Bowie and the unacceptable rates of Black maternal death

Maker of FluMist seeks to allow at

entertainment

Readout Newsletter: What happened with Sarepta's Duchenne data

Cue Health's Covid

Why rehabilitation engineers need to center patients in their research

More tobacco lobbyists active in statehouses

Traditional Chinese medicine benefits explored in new JAMA study

Getting Alzheimer's drug Leqembi to patients can be a challenge

hotspot

leisure time

explore

knowledge